US20220033789A1 - Gdsl lipase, genetically-engineered bacteria and application thereof - Google Patents
Gdsl lipase, genetically-engineered bacteria and application thereof Download PDFInfo
- Publication number
- US20220033789A1 US20220033789A1 US17/279,733 US201917279733A US2022033789A1 US 20220033789 A1 US20220033789 A1 US 20220033789A1 US 201917279733 A US201917279733 A US 201917279733A US 2022033789 A1 US2022033789 A1 US 2022033789A1
- Authority
- US
- United States
- Prior art keywords
- vitamin
- lipase
- palmitate
- gdsl
- olive oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Definitions
- the present invention relates to the fields of genetic engineering and protein engineering and to a method for gene cloning and expression of a new type of GDSL lipase and an application in the production of vitamin A palmitate by the enzymatic method and pertains to a technology in the industrial microorganism field.
- Lipase also known as triacylglycerol lipase, is a type of enzymes that can degrade natural oils into glycerol and free fatty acids. It is widely found in animals, plants and microorganisms. Microorganisms are an important source of lipase, mainly including Rhizopus, Aspergillus and Candida . According to the analysis of the amino acid sequences of different lipases and their basic biological properties, lipases can be divided into eight families, of which the second family is also known as a GDSL family.
- GDSL lipase (lipase, EC 3.1.1.3) is a type of hydrolase that can hydrolyze various substrates such as thioesters, aryl esters, phospholipids and amino acids. As GDSL lipase is a new type of lipase, little research has been done on its expression and function. Because GDSL lipase has ester hydrolysis activity, people are deepening the research on it.
- Vitamin A palmitate can help maintain normal visual function and participate in various metabolic activities to maintain the health of the organisms. It is currently the most commonly used vitamin A derivative and is widely used in various industries such as food, cosmetics and medicine. At present, vitamin A palmitate is synthesized mainly by the chemical method and the enzymatic method. The chemical method for the synthesis of vitamin A palmitate has problems such as environmental pollution and cost, while the enzymatic method features less pollution, high space-time yield and low cost.
- the enzyme that is used to produce vitamin A palmitate is a lipase with ester hydrolysis activity.
- the object of the present invention is to provide a GDSL lipase, genetically-engineered bacteria and an application thereof.
- the lipase has high activity and can be used in the production of vitamin A palmitate.
- the present invention adopts the following technical solution:
- a GDSL lipase wherein its amino acid sequence is as shown in SEQ ID NO.2.
- the present invention further provides a gene encoding the foregoing GDSL lipase.
- nucleotide sequence of the gene encoding the GDSL lipase is as shown in SEQ ID NO.1.
- GDSL lipase is derived from Streptomyces diastaticus CS1801, which has been disclosed in the applicant's prior application CN109337843A.
- the present invention further provides a recombinant vector, comprising the gene encoding the GDSL lipase and an expression vector, and the nucleotide sequence of the gene is as shown in SEQ ID NO.1.
- the expression vector is pET-32a (+).
- the foregoing gene is inserted between multiple cloning sites of the expression vector pET-32a (+).
- the present invention further provides a genetically-engineered bacterium containing the foregoing recombinant vector.
- the host cell of the engineered bacterium is E. coli BL21(DE3).
- the present invention further provides an application of the foregoing engineered bacterium in the production of vitamin A palmitate by the enzymatic method, including:
- the fermentation medium comprises:
- tryptone 10 g/L tryptone 10 g/L, yeast powder 5 g/L, NaCl 10 g/L, MgSO 4 .7H 2 O 1 g/L, KH 2 PO 4 0.5 g/L, K 2 HPO 4 0.5 g/L, and olive oil emulsion 12 mL/L.
- an olive oil emulsifier is prepared by the following method: mixing olive oil emulsifier PVA with olive oil at a volume ratio of 3:1 and emulsifying the mixture by ultrasound.
- the genetically-engineered bacterium constructed by the enzyme in the present invention is used to produce vitamin A palmitate by the enzymatic method.
- the content of the vitamin A palmitate obtained from conversion is 16.35 mg/L at most.
- the maximum conversion rate is 81.75%.
- This lipase provides a new path to synthesize vitamin A palmitate by the enzymatic method and has an important application prospect.
- FIG. 1 shows target strips of PCR amplification of GDSL lipase
- FIG. 2 is an SDS-PAGE electrophoretogram of E. coli
- FIG. 3 shows the conversion time of GDSL lipase in the production of vitamin A palmitate.
- This embodiment describes a method for PCR amplification of GDSL lipase derived from Streptomyces diastaticus.
- Streptomyces diastaticus CS1801 stored on a test tube slant is used for plate activation, and a single colony is inoculated to an LB liquid medium and cultured at 30° C. for 2 ⁇ 3 days.
- the culture solution is centrifuged at 8000 r for 2 min, thalli are collected and a bacterial genome extraction kit is used for total genome extraction.
- the extraction steps are described in the bacterial genome extraction kit manual of Sangon Biotech (Shanghai) Co., Ltd.
- the primers for GDSL lipase gene amplification are designed as follows:
- GDSL2-up 5′ -GTGGCCGGGCTCACGTCCTC-3′
- GDSL2-down 5′ -TCATTCCGGCAGGCTCCG-3′
- the extracted Streptomyces diastaticus genome is used as a template, and the above primers and a PCR amplification kit with high GC content from Sangon Biotech (Shanghai) Co., Ltd. are used for amplification, but no Taq enzyme is added.
- the specific amplification procedure is as follows: pre-denature at 95° C. for 10 min and add Taq enzyme; denature at 95° C. for 1 min, anneal at 55° C. for 30 s, extend at 72° C. for 1 min, repeat this process for 29 cycles and lastly extend at 72° C. for 30 min; and take the product to perform agarose gel electrophoresis (AGE), cut gel and extract and store target strips.
- the gel extraction kit is purchased from Sangon Biotech (Shanghai) Co., Ltd.
- This embodiment describes the PCR amplification method of GDSL lipase gene with restriction enzyme cutting sites.
- the primers for amplification of GDSL lipase gene with restriction enzyme cutting sites are designed as follows:
- GDSL2-up 5′ -CCGGAATTCGTGGCCGGGCTCACGTCCTC-3′
- GDSL2-down 5′ -CCGCTCGAGTCATTCCGGCAGGCTCCG-3′
- Embodiment 1 The gel extraction product in Embodiment 1 is used as a template, and the above primers and a PCR amplification kit with high GC content from Sangon Biotech (Shanghai) Co., Ltd. are used for amplification.
- the specific amplification procedure is as follows: pre-denature at 95° C. for 2 min; denature at 95° C. for 1 min, anneal at 55° C. for 30 s, extend at 72° C. for 1 min, repeat this process for 29 cycles and lastly extend at 72° C. for 30 min; and take the product to perform agarose gel electrophoresis (AGE), and cut gel, extract the target strips as shown in FIG. 1 and send them to Sangon Biotech (Shanghai) Co., Ltd. for sequence measurement to obtain sequence SEQ ID NO.1.
- AGE agarose gel electrophoresis
- This embodiment describes a method for constructing a recombinant cloning vector of GDSL lipase.
- the gel extraction product in Embodiment 2 is linked to a T vector. After conversion to DH-5a, positive clones are picked for verification. After extraction of plasmid, the sequence is measured for verification.
- This embodiment describes a method for constructing a recombinant expression vector of GDSL lipase.
- XhoI and EcoRI are used to perform double digestion of the plasmid in Embodiment 3 and extract target strips, meanwhile XhoI and EcoRI are used to perform double digestion of pET32a(+) vector and extract large fragments in the vector, the extracted target gene fragments are linked to vector fragments and they are imported to host cell E. coli DH5a. After resistance screening, positive clones are picked to measure the sequence for verification.
- This embodiment describes a method for constructing genetically-engineered bacteria of GDSL lipase.
- the plasmid of the positive clones with a correct sequence in Embodiment 4 is extracted and directly converted and imported to host cell E. coli BL21 (DE3). Genetically-engineered bacteria of GDSL lipase are successfully constructed. In the fermentation process, an inducer like IPTG needs to be added to efficiently express GDSL lipase protein. Through SDS-PAGE, it is verified that the fusion protein is successfully expressed. SDS-PAGE electrophoretogram is as shown in FIG. 2 , lane 1 is E. coli pET32a-GDSL not induced, and lanes 2, 3 and 4 are recombinant E. coli pET32a-GDSL that has been induced by IPTG for 4, 8 and 16 h, respectively.
- This embodiment describes an application of genetically-engineered bacteria of GDSL lipase in vitamin A palmitate.
- the fermentation medium comprises:
- tryptone 10 g/L tryptone 10 g/L, yeast powder 5 g/L, NaCl 10 g/L, MgSO 4 .7H 2 O 1 g/L, KH 2 PO 4 0.5 g/L, K 2 HPO 4 0.5 g/L, olive oil emulsion 12 mL/L, and distilled water added till volume 1 L.
- the olive oil emulsion is prepared by the following method: mixing olive oil emulsifier PVA with olive oil at a volume ratio of 3:1 and emulsifying the mixture by ultrasound.
- the vitamin A palmitate is determined by HPLC and quantitatively determined by the external standard method. Chromatographic conditions: chromatographic column: Alltech C18 (250 ⁇ 4.6 mm, 4.5 ⁇ m); mobile phase: 100% methanol; detector: Shimadzu 10A ultraviolet detector; detection wavelength: 327 nm; flow rate: 1 mL/min.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
- The present invention relates to the fields of genetic engineering and protein engineering and to a method for gene cloning and expression of a new type of GDSL lipase and an application in the production of vitamin A palmitate by the enzymatic method and pertains to a technology in the industrial microorganism field.
- Lipase, also known as triacylglycerol lipase, is a type of enzymes that can degrade natural oils into glycerol and free fatty acids. It is widely found in animals, plants and microorganisms. Microorganisms are an important source of lipase, mainly including Rhizopus, Aspergillus and Candida. According to the analysis of the amino acid sequences of different lipases and their basic biological properties, lipases can be divided into eight families, of which the second family is also known as a GDSL family. GDSL lipase (lipase, EC 3.1.1.3) is a type of hydrolase that can hydrolyze various substrates such as thioesters, aryl esters, phospholipids and amino acids. As GDSL lipase is a new type of lipase, little research has been done on its expression and function. Because GDSL lipase has ester hydrolysis activity, people are deepening the research on it.
- Vitamin A palmitate can help maintain normal visual function and participate in various metabolic activities to maintain the health of the organisms. It is currently the most commonly used vitamin A derivative and is widely used in various industries such as food, cosmetics and medicine. At present, vitamin A palmitate is synthesized mainly by the chemical method and the enzymatic method. The chemical method for the synthesis of vitamin A palmitate has problems such as environmental pollution and cost, while the enzymatic method features less pollution, high space-time yield and low cost. The enzyme that is used to produce vitamin A palmitate is a lipase with ester hydrolysis activity.
- The object of the present invention is to provide a GDSL lipase, genetically-engineered bacteria and an application thereof. The lipase has high activity and can be used in the production of vitamin A palmitate.
- In order to achieve the above object, the present invention adopts the following technical solution:
- A GDSL lipase, wherein its amino acid sequence is as shown in SEQ ID NO.2.
- The present invention further provides a gene encoding the foregoing GDSL lipase.
- Specifically, the nucleotide sequence of the gene encoding the GDSL lipase is as shown in SEQ ID NO.1.
- The foregoing GDSL lipase is derived from Streptomyces diastaticus CS1801, which has been disclosed in the applicant's prior application CN109337843A.
- The present invention further provides a recombinant vector, comprising the gene encoding the GDSL lipase and an expression vector, and the nucleotide sequence of the gene is as shown in SEQ ID NO.1. The expression vector is pET-32a (+). The foregoing gene is inserted between multiple cloning sites of the expression vector pET-32a (+).
- The present invention further provides a genetically-engineered bacterium containing the foregoing recombinant vector.
- Further, the host cell of the engineered bacterium is E. coli BL21(DE3).
- The present invention further provides an application of the foregoing engineered bacterium in the production of vitamin A palmitate by the enzymatic method, including:
- (1) inoculating the engineered bacterium to an LB medium for seed culture;
- (2) transferring the seed solution to a fermentation medium for fermentation culture, and then adding an inducer to induce expression of enzymes;
- (3) centrifuging the fermentation broth to obtain a supernate, and obtaining enzyme powder through precipitation by ammonium sulfate and lyophilization; and
- (4) adding the enzyme powder to an organic phase system containing vitamin A and palmitic acid to produce vitamin A palmitate.
- Specifically, the method includes: inoculating the engineered bacteria cultured in an LB medium at 37° C., 200 r for 8˜12 h to a fermentation medium in an inoculum size of 5%; fermenting them for 8˜12 h, then adding IPTG till a final concentration of 0.4˜1 mmol/L and fermenting and culturing at 37° C., 200 r for 18˜24 h; centrifuging at 4000 r for 10 min to obtain a supernate of the fermentation broth; precipitating zymoprotein by 50% ammonium sulfate and lyophilizing the precipitate for 48 h to obtain enzyme powder; and adding the enzyme powder to an organic phase system (vitamin A: palmitic acid=10 g: 10 g, dissolved in 1 L of normal hexane) at a ratio of 5%, and determining the content of vitamin A palmitate and calculating the conversion rate after a specific time of conversion.
- Further, the fermentation medium comprises:
- tryptone 10 g/L, yeast powder 5 g/L, NaCl 10 g/L, MgSO4.7H2O 1 g/L, KH2PO4 0.5 g/L, K2HPO4 0.5 g/L, and
olive oil emulsion 12 mL/L. - Further, an olive oil emulsifier is prepared by the following method: mixing olive oil emulsifier PVA with olive oil at a volume ratio of 3:1 and emulsifying the mixture by ultrasound.
- The genetically-engineered bacterium constructed by the enzyme in the present invention is used to produce vitamin A palmitate by the enzymatic method. The content of the vitamin A palmitate obtained from conversion is 16.35 mg/L at most. The maximum conversion rate is 81.75%. This lipase provides a new path to synthesize vitamin A palmitate by the enzymatic method and has an important application prospect.
-
FIG. 1 shows target strips of PCR amplification of GDSL lipase; -
FIG. 2 is an SDS-PAGE electrophoretogram of E. coli; -
FIG. 3 shows the conversion time of GDSL lipase in the production of vitamin A palmitate. - This embodiment describes a method for PCR amplification of GDSL lipase derived from Streptomyces diastaticus.
- Streptomyces diastaticus CS1801 stored on a test tube slant is used for plate activation, and a single colony is inoculated to an LB liquid medium and cultured at 30° C. for 2˜3 days. The culture solution is centrifuged at 8000 r for 2 min, thalli are collected and a bacterial genome extraction kit is used for total genome extraction. The extraction steps are described in the bacterial genome extraction kit manual of Sangon Biotech (Shanghai) Co., Ltd.
- The primers for GDSL lipase gene amplification are designed as follows:
-
GDSL2-up: 5′ -GTGGCCGGGCTCACGTCCTC-3′ GDSL2-down: 5′ -TCATTCCGGCAGGCTCCG-3′ - The extracted Streptomyces diastaticus genome is used as a template, and the above primers and a PCR amplification kit with high GC content from Sangon Biotech (Shanghai) Co., Ltd. are used for amplification, but no Taq enzyme is added.
- The specific amplification procedure is as follows: pre-denature at 95° C. for 10 min and add Taq enzyme; denature at 95° C. for 1 min, anneal at 55° C. for 30 s, extend at 72° C. for 1 min, repeat this process for 29 cycles and lastly extend at 72° C. for 30 min; and take the product to perform agarose gel electrophoresis (AGE), cut gel and extract and store target strips. The gel extraction kit is purchased from Sangon Biotech (Shanghai) Co., Ltd.
- This embodiment describes the PCR amplification method of GDSL lipase gene with restriction enzyme cutting sites.
- The primers for amplification of GDSL lipase gene with restriction enzyme cutting sites are designed as follows:
-
GDSL2-up: 5′ -CCGGAATTCGTGGCCGGGCTCACGTCCTC-3′ GDSL2-down: 5′ -CCGCTCGAGTCATTCCGGCAGGCTCCG-3′ - The gel extraction product in
Embodiment 1 is used as a template, and the above primers and a PCR amplification kit with high GC content from Sangon Biotech (Shanghai) Co., Ltd. are used for amplification. - The specific amplification procedure is as follows: pre-denature at 95° C. for 2 min; denature at 95° C. for 1 min, anneal at 55° C. for 30 s, extend at 72° C. for 1 min, repeat this process for 29 cycles and lastly extend at 72° C. for 30 min; and take the product to perform agarose gel electrophoresis (AGE), and cut gel, extract the target strips as shown in
FIG. 1 and send them to Sangon Biotech (Shanghai) Co., Ltd. for sequence measurement to obtain sequence SEQ ID NO.1. - This embodiment describes a method for constructing a recombinant cloning vector of GDSL lipase.
- The gel extraction product in
Embodiment 2 is linked to a T vector. After conversion to DH-5a, positive clones are picked for verification. After extraction of plasmid, the sequence is measured for verification. - This embodiment describes a method for constructing a recombinant expression vector of GDSL lipase.
- XhoI and EcoRI are used to perform double digestion of the plasmid in
Embodiment 3 and extract target strips, meanwhile XhoI and EcoRI are used to perform double digestion of pET32a(+) vector and extract large fragments in the vector, the extracted target gene fragments are linked to vector fragments and they are imported to host cell E. coli DH5a. After resistance screening, positive clones are picked to measure the sequence for verification. - This embodiment describes a method for constructing genetically-engineered bacteria of GDSL lipase.
- The plasmid of the positive clones with a correct sequence in
Embodiment 4 is extracted and directly converted and imported to host cell E. coli BL21 (DE3). Genetically-engineered bacteria of GDSL lipase are successfully constructed. In the fermentation process, an inducer like IPTG needs to be added to efficiently express GDSL lipase protein. Through SDS-PAGE, it is verified that the fusion protein is successfully expressed. SDS-PAGE electrophoretogram is as shown inFIG. 2 ,lane 1 is E. coli pET32a-GDSL not induced, andlanes - This embodiment describes an application of genetically-engineered bacteria of GDSL lipase in vitamin A palmitate.
- (1) Inoculate the genetically-engineered bacteria cultured in an LB medium at 37° C., 200 r for 8˜12 h to a fermentation medium in an inoculum size of 5%.
- (2) Ferment them for 8˜12 h, add IPTG till a final concentration of 0.4˜1 mmol/L, and ferment and culture at 37° C., 200 r for 18˜24 h.
- (3) Centrifuge at 4000 r for 10 min to get a supernate of the fermentation broth; use a 50% ammonium sulfate solution to precipitate zymoprotein, lyophilize it for 48 h to obtain enzyme powder, and determine the enzyme activity of GDSL lipase according to the national standard GBT23535-2009, which is 1.53 U/mg.
- (4) Add 5% (w/v) enzyme powder to an organic phase system (vitamin A: palmitic acid=10 g: 10 g, dissolved in 1 L of normal hexane), determine the content of vitamin A palmitate after 2, 4, 6, 8 and 10 h of conversion and calculate the conversion rates. As shown in
FIG. 3 , after 8 h of conversion, the content of vitamin A palmitate is 16.35 mg/L at most and the conversion rate is 81.75%. - The fermentation medium comprises:
- tryptone 10 g/L, yeast powder 5 g/L, NaCl 10 g/L, MgSO4.7H2O 1 g/L, KH2PO4 0.5 g/L, K2HPO4 0.5 g/L,
olive oil emulsion 12 mL/L, and distilled water added till volume 1 L. - The olive oil emulsion is prepared by the following method: mixing olive oil emulsifier PVA with olive oil at a volume ratio of 3:1 and emulsifying the mixture by ultrasound.
- The vitamin A palmitate is determined by HPLC and quantitatively determined by the external standard method. Chromatographic conditions: chromatographic column: Alltech C18 (250×4.6 mm, 4.5 μm); mobile phase: 100% methanol; detector: Shimadzu 10A ultraviolet detector; detection wavelength: 327 nm; flow rate: 1 mL/min.
- Calculation formula of conversion rate:
-
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910199413.XA CN109777793B (en) | 2019-03-15 | 2019-03-15 | GDSL lipase, genetically engineered bacterium and application thereof |
CN201910199413.X | 2019-03-15 | ||
PCT/CN2019/114789 WO2020186768A1 (en) | 2019-03-15 | 2019-10-31 | Gdsl lipase, genetically-engineered bacteria and application thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/114789 A-371-Of-International WO2020186768A1 (en) | 2019-03-15 | 2019-10-31 | Gdsl lipase, genetically-engineered bacteria and application thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/341,792 Continuation US20240011001A1 (en) | 2019-03-15 | 2023-06-27 | Gdsl lipase, genetically-engineered bacteria and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220033789A1 true US20220033789A1 (en) | 2022-02-03 |
Family
ID=66489366
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/279,733 Abandoned US20220033789A1 (en) | 2019-03-15 | 2019-10-31 | Gdsl lipase, genetically-engineered bacteria and application thereof |
US18/341,792 Pending US20240011001A1 (en) | 2019-03-15 | 2023-06-27 | Gdsl lipase, genetically-engineered bacteria and application thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/341,792 Pending US20240011001A1 (en) | 2019-03-15 | 2023-06-27 | Gdsl lipase, genetically-engineered bacteria and application thereof |
Country Status (5)
Country | Link |
---|---|
US (2) | US20220033789A1 (en) |
JP (1) | JP7162374B2 (en) |
CN (1) | CN109777793B (en) |
SG (1) | SG11202103103TA (en) |
WO (1) | WO2020186768A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109777793B (en) * | 2019-03-15 | 2020-12-08 | 常熟理工学院 | GDSL lipase, genetically engineered bacterium and application thereof |
CN110564649B (en) * | 2019-09-27 | 2021-05-18 | 常熟理工学院 | Strain for producing lipase and application thereof |
CN113481186B (en) * | 2021-06-15 | 2023-01-03 | 常熟理工学院 | GH18 chitinase ChiA and application thereof |
CN114854717B (en) * | 2022-05-07 | 2023-08-11 | 万华化学集团股份有限公司 | Lipase and encoding gene and application thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62248495A (en) * | 1986-04-23 | 1987-10-29 | Mihama Hisaharu | Production of vitamin a ester |
KR100745832B1 (en) * | 2006-02-23 | 2007-08-02 | 고려대학교 산학협력단 | 1 GLIP1 gene and its protein having plant resistance to the fungus |
CN101200740A (en) * | 2007-12-18 | 2008-06-18 | 北京化工大学 | Method for preparing vitamin A fatty acid ester by lipase catalysis |
US20120263858A1 (en) * | 2009-12-21 | 2012-10-18 | Bakan Benedicte | Isolated plant gdsl lipase |
CN102212601B (en) * | 2011-04-28 | 2013-08-14 | 浙江大学 | Method for performing catalytic synthesis of vitamin A palmitate by using yeast display lipase |
CN102876643A (en) * | 2012-09-21 | 2013-01-16 | 中国农业科学院饲料研究所 | New application of GDSL protein to preparation of lipase |
TW202330904A (en) * | 2015-08-04 | 2023-08-01 | 美商再生元醫藥公司 | Taurine supplemented cell culture medium and methods of use |
CN108866086B (en) * | 2018-07-26 | 2020-07-10 | 福建农林大学 | Rice gene OsGDS L1 and application thereof in resisting rice blast |
CN109337843B (en) * | 2018-11-19 | 2020-12-15 | 常熟理工学院 | Bacterial strain for producing chitinase and application thereof |
CN109777793B (en) * | 2019-03-15 | 2020-12-08 | 常熟理工学院 | GDSL lipase, genetically engineered bacterium and application thereof |
-
2019
- 2019-03-15 CN CN201910199413.XA patent/CN109777793B/en active Active
- 2019-10-31 US US17/279,733 patent/US20220033789A1/en not_active Abandoned
- 2019-10-31 SG SG11202103103TA patent/SG11202103103TA/en unknown
- 2019-10-31 JP JP2021521961A patent/JP7162374B2/en active Active
- 2019-10-31 WO PCT/CN2019/114789 patent/WO2020186768A1/en active Application Filing
-
2023
- 2023-06-27 US US18/341,792 patent/US20240011001A1/en active Pending
Non-Patent Citations (4)
Title |
---|
Badalamenti. A0A126Y261_9ACTN. UnitProtKB Database. June 8, 2016 * |
Doyle. A0A380MP40_STRGR. UnitProtKB Database. November 7, 2018 * |
Ichikawa (GFH64141. GenBank Database. February 28, 2020 * |
Studer. Residue mutations and their impact on protein structure and function: detecting beneficial and pathogenic changes. Biochem. J. (2013) 449, 581–594. * |
Also Published As
Publication number | Publication date |
---|---|
US20240011001A1 (en) | 2024-01-11 |
JP2022505573A (en) | 2022-01-14 |
SG11202103103TA (en) | 2021-04-29 |
CN109777793A (en) | 2019-05-21 |
JP7162374B2 (en) | 2022-10-28 |
WO2020186768A1 (en) | 2020-09-24 |
CN109777793B (en) | 2020-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240011001A1 (en) | Gdsl lipase, genetically-engineered bacteria and application thereof | |
CN103361326B (en) | Partial glyceride lipase mutant with improved thermal resistance, mutant plasmid, recombination strain and preparation method | |
Abdel-Fattah et al. | Identification and over-expression of a thermostable lipase from Geobacillus thermoleovorans Toshki in Escherichia coli | |
CN106957850B (en) | Genetically engineered bacterium for producing phospholipase D and construction method and application thereof | |
CN103627685B (en) | Higher-activity partial glyceride lipase mutant and application thereof | |
CN103525784A (en) | Partial glyceride lipase mutant, plasmids, recombination strains, preparation methods and applications | |
CN102965355B (en) | Carboxylesterase and application thereof in degradation of pesticides malathion and carbaryl | |
CN106062178A (en) | Methods and organisms with increased carbon flux efficiencies | |
CN109929822A (en) | A kind of Aspergillus oryzae lipase mutant and its application | |
CN108410789A (en) | The microorganism of production Polyurethane-epoxy resin and its construction method and application | |
CN102174432B (en) | Organic-solvent-resistant high-activity lipase-producing strain and gene of lipase produced thereby as well as application thereof | |
CN102329745B (en) | High-stability organic solvent-resistant lipase producing strain and lipase as well as gene and application thereof | |
CN113789307B (en) | Pantothenate synthetase mutant, encoding gene, vector and application | |
CN104694523A (en) | Extracellular expression method of arginine deiminase and application thereof | |
CN108795836A (en) | A kind of genetic engineering bacterium of synthesis mannitol and its construction method and application | |
CN105861463B (en) | Epoxysuccinic acid hydrolase and its carrier and application | |
CN102174422A (en) | Lipase producing strain tolerant to organic solvent as well as genes and applications of lipase | |
CN107384975B (en) | Biological safety Klebsiella variicola and application thereof in production of 1, 3-propylene glycol | |
CN109929853A (en) | The application of the heat shock protein gene in Thermophilic Bacteria source | |
CN108949785A (en) | Application of the sporulation related gene spo0A in producing enzyme | |
CN100587072C (en) | Thermophilic esterase/phosphatidase gene, engineering bacteria, enzyme and use thereof | |
CN103468664B (en) | Method for promoting efficient water-soluble expression of arginine deiminase | |
CN103194432A (en) | Novel maltooligosyl trehalose synthase, gene of synthase, recombinant expression vector containing gene, and recombinant bacterium, and preparation of synthase | |
US20220002689A1 (en) | Feruloyl Esterase and Application thereof | |
Yufidasari et al. | CHARACTERIZATION OF PREDICTED BACTERIAL COLD-ADAPTED LIPASE FROM SEAFOOD COLD STORAGE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CHANGSHU INSTITUTE OF TECHNOLOGY, CHINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WANG, LIMEI;XU, TIANTIAN;JI, YAMEI;AND OTHERS;REEL/FRAME:055714/0894 Effective date: 20210318 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |